Oncodesign Services

Preclinical Development > GLP-grade Bioanalysis

Oncodesign Services is a leading CRO specializing in drug discovery and preclinical services. The company contributes to developing innovative therapies in oncology, inflammation, and infectious diseases through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vivo/in vitro pharmacology. Oncodesign Services has 230 employees in France, Canada, and the United States.


Stephane Richard Director, Drug Discovery Business Development Phone: +1 (858) 342 6807
20 Rue Jean Mazen FR-21076 Dijon Cedex, France